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Host colonisation by lymphotropic gammaherpesviruses
depends critically on the expansion of viral genomes in
germinal centre (GC) B cells. Yet, host and virus molecular
mechanisms involved in driving such proliferation remain
largely unknown. Here, we show that the ORF73 protein
encoded by the murid herpesvirus-4 (MuHV-4) inhibits
host nuclear factor-kappa B (NF-jB) transcriptional activ-
ity through poly-ubiquitination and subsequent proteaso-
mal-dependent nuclear degradation of the NF-jB family
member p65/RelA. The mechanism involves the assembly
of an ElonginC/Cullin5/SOCS (suppressors of cytokine
signalling)-like complex, mediated by an unconventional
viral SOCS-box motif present in ORF73. Functional dele-
tion of this SOCS-box motif ablated NF-jB inhibitory effect
of ORF73, suppressed MuHV-4 expansion in GC
B cells and prevented MuHV-4 persistent infection in
mice. These ﬁndings demonstrate that viral inhibition
of NF-jB activity in latently infected GC centroblasts is
critical for the establishment of a gammaherpesvirus
persistent infection, underscoring the physiological
importance of proteasomal degradation of RelA/NF-jBa s
a regulatory mechanism of this signalling pathway.
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Introduction
Being obligatory intracellular parasites, viruses have evolved
a variety of mechanisms to modulate speciﬁc host signal-
transduction pathways to favour their own replication. One of
such mechanisms targets nuclear factor-kappa B (NF-kB), a
family of ubiquitously expressed transcription factors that
bind speciﬁc DNA sequences, kB sites, in the promoter region
of a variety of genes, to modulate their rate of transcription/
expression. In mammalian cells, the NF-kB family comprises
ﬁve members—p65/RelA, RelB, c-Rel, p105/p50 and p100/
p52 (Blank et al, 1992)—that can form homo- or heterodi-
mers (Saccani et al, 2003). Under homoeostasis, NF-kB
dimers are sequestered in the cytoplasm by the inhibitory
IkB proteins, which include IkBa,I kBb and IkBe. These mask
the nuclear localisation signal of the NF-kB dimers, impairing
their nuclear translocation. Once exposed to pro-inﬂamma-
tory stimuli, mammalian cells activate an IkB kinase (IKK)
complex that phosphorylates IkB molecules leading to their
poly-ubiquitination and proteasomal degradation. This, in
turn, promotes nuclear translocation of NF-kB dimers,
where they bind to euchromatised kB sites to activate target
gene transcription (Karin and Ben-Neriah, 2000).
Genes regulated through NF-kB are involved in critical
biological functions, including inﬂammation and apoptosis as
well as cell proliferation. One essential aspect of the NF-kB
signal-transduction pathway is that it must be tightly regu-
lated to afford a fast response to a given stimulus, terminating
this response as soon as the stimulus is no longer present.
Although mechanisms regulating NF-kB activation have been
studied extensively, those regulating its termination are less
well perceived. Termination of NF-kB activity was initially
thought to rely exclusively on the de novo expression of IkB
molecules. Once resynthesised, IkBa enters the nucleus
where it dissociates NF-kB dimers from kB sites, shuttling
NF-kB dimers back to the cytoplasm (Arenzana-Seisdedos
et al, 1997). However, in recent years, it has become apparent
that many other mechanisms control the extent of NF-kB
activation, including direct poly-ubiquitination and subse-
quent proteasomal degradation of promoter-bound RelA
(Saccani et al, 2004). This mechanism is regulated through
the activation of multimeric E3 ubiquitin-ligases, which
accept ubiquitin from E2 ubiquitin-conjugating enzymes,
and transfer it to speciﬁc substrates promoting their degrada-
tion by the proteasome (Weissman, 2001). Two cellular
proteins, PDLIM2 (Tanaka et al, 2007) and SOCS1 (suppres-
sors of cytokine signalling 1; Ryo et al, 2003), have been
identiﬁed as mediators of RelA poly-ubiquitination. In the
case of SOCS1, this protein functions as the substrate recog-
nition component of an ECS (ElonginC–Cullin2/5–SOCS) E3
ubiquitin-ligase (Ryo et al, 2003). SOCS proteins comprise
several family members each of which share a C-terminal
40-amino-acid module that is known as the SOCS-box, which
mediates the interaction with ElonginB/C and Cullin2/5
modules, bridging the substrate of ubiquitination to the E2
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1283ubiquitin-conjugating enzyme (Yoshimura et al, 2007). By
virtue of assembling an ECS
SOCS1 ligase and interacting with
NF-kB subunits, SOCS1 directs ubiquitination and proteaso-
mal degradation of promoter-bound NF-kB members and
efﬁcient termination of transcriptional responses (Ryo et al,
2003; Saccani et al, 2004).
Viruses have evolved several mechanisms to modulate
NF-kB activity (Hiscott et al, 2006). One example is the
NS5B protein of hepatitis C virus that targets the IKK complex
resulting in IKK inhibition and suppression of NF-kB activity
(Choi et al, 2006). Another strategy relies on the expression of
viral IkB-like proteins that stably interact with NF-kB dimers,
but lack the consensus serine residues phosphorylated by
IKK. Thus, these viral inhibitors are not degraded in response
to IKK activation, which prevents NF-kB translocation to the
nucleus and the subsequent NF-kB-driven gene transcription.
This is the case for the A238L IkB-like protein of African
swine fever virus (Powell et al, 1996; Revilla et al, 1998; Tait
et al, 2000). In addition, host NF-kB dimers can be targeted
directly for degradation by viral proteins, as exempliﬁed by
the 3C-encoded protease of poliovirus that cleaves the trans-
activation domain (TAD) of RelA to inhibit NF-kB signalling
(Neznanov et al, 2005).
In this study, we describe a novel viral mechanism to
suppress NF-kB activity. We provide conclusive evidence
that the latency-associated protein ORF73 encoded by murid
herpesvirus-4 (MuHV-4), a gammaherpesvirus genetically re-
lated to the human pathogens Epstein–Barr virus (EBV) and
Kaposi’s sarcoma-associated herpesvirus (KSHV) (Simas and
Efstathiou, 1998), targets nuclear RelA for proteasomal degra-
dation. Gammaherpesviruses are among the most prevalent of
human pathogens owing to their ability to cause persistent
infections (Rickinson and Kieff, 2001). Persistent infection is
associated with both lymphoid and epithelial tumours, which
occur with increased incidence following immune suppression
(Damania, 2004; Sunil-Chandra et al, 1994). Thus, the control
of gammaherpesvirus infections represents a major clinical
goal. A critical determinant of persistence is the ability to
establish latency in memory B cells. Access to this cell type is
gained by virus-driven lymphoproliferation of germinal centre
(GC) B cells (Thorley-Lawson, 2001). During expansion of
latency in B cells, viral genomes replicate in step with normal
cell division. This process is mediated by viral episome main-
tenance proteins, which include Epstein–Barr nuclear antigen-
1 (EBNA-1) of EBV (Yates et al, 1985) and ORF73 of gamma-2-
herpesviruses (Ballestas et al, 1999; Hall et al, 2000). ORF73
proteins have also been shown to function as nuclear regula-
tors of transcription and to interact with several cellular
proteins to modulate host functions, postulated to be involved
in latency regulation (Verma et al, 2007). The new mechanism
here described underlying ORF73-mediated RelA degradation,
involves the assembly of an EC5S complex mediated by an
unconventional SOCS-box-like motif present in ORF73. We
found that EC5S
ORF73 mimics the host ECS
SOCS1 ubiquitin-
ligase inhibiting tumour necrosis factor (TNF)-induced
NF-kB activation. Infection with recombinant viruses, bearing
disruptive mutations in the ORF73 SOCS-box-like motif, ren-
dered these viruses incapable of inducing lymphoproliferation
in GC B cells and prevented persistent infection in mice. This
ﬁnding emphasises the physiological importance of proteaso-
mal degradation of NF-kB as a prompt terminator of this
signalling pathway.
Results
Identiﬁcation of ORF73 as an inhibitor of NF-jB
transcriptional activity
Experiments were designed to investigate whether NF-kB
transcriptional activity was modulated in mammalian cells
transiently expressing ORF73. Human HEK 293T cells were
transiently co-transfected with a synthetic NF-kB reporter
containing three copies of kB consensus sequences driving
the expression of ﬁreﬂy luciferase (Winkler et al, 1996), with
or without ORF73. TNF was used as a prototypical stimulus
leading to NF-kB activation. Control cells, which did not
express ORF73, responded in a dose-dependent manner to
TNF; that is, the higher the TNF concentration the higher the
luciferase activity (Figure 1A, ﬁlled bars). In contrast, cells
expressing ORF73 were unable to respond effectively to
TNF, even at the highest concentration tested (50ng/ml)
(Figure 1A, open bars), an indication that the viral protein
impairs TNF-driven NF-kB activation.
We next assessed whether ORF73 would be modulating the
NF-kB inhibitor IkBa by interfering with its degradation and/
or resynthesis kinetics. Control transfected or ORF73-expres-
sing cells, exposed to TNF, were monitored by western blot
for the expression of IkBa. The pattern of IkBa degradation
was similar in control versus ORF73-expressing cells
(Figure 1B, ﬁrst panel, lanes T0 and T1), indicating that
ORF73 does not modulate the signal-transduction pathway,
driven by TNF receptor 1 (TNFR1), that leads to IkBa
degradation. However, IkBa resynthesis was severely com-
promised in ORF73-expressing cells (Figure 1B, ﬁrst panel,
lanes T2–T4). These results are in good agreement with the
inhibitory effect observed for the reporter assay, as IkBa is
one of the primary targets of NF-kB transcriptional activity.
ORF73 directly targets the Rel homology domain of RelA
Next, we hypothesised that ORF73 was directly targeting one
or more members of the NF-kB family. We performed reporter
gene assays where the primary NF-kB family member, RelA,
was transiently overexpressed in different combinations with
p50 and c-Rel, in the presence or absence of ORF73.
Overexpression of these NF-kB family members over-rides
the sequestering effect of endogenous IkB molecules
(Anrather et al, 1999), as revealed by a signiﬁcant fold
induction of NF-kB transcriptional activity (Figure 1C,
ﬁlled bars). Co-expression of ORF73 resulted in the inhibition
of the transcriptional activity in all NF-kB combinations
tested (Figure 1C, open bars), an indication that ORF73
directly targets NF-kB proteins to inhibit their transcriptional
activity.
The Rel homology domain (RHD) is a consensus sequence
shared by all NF-kB proteins: RelA, RelB, c-Rel, p105/p50 and
p100/p52. RelA, RelB and c-Rel contain an additional TAD
responsible for interaction with the basal transcriptional
machinery (Chen and Greene, 2004). To investigate which
functional RelA domain was targeted by ORF73, we used two
artiﬁcial fusion proteins depicted in Figure 1D (Anrather et al,
1999). The RelA(RHD)–VP16 fusion protein is composed of
the RHD of RelA (aa 2–320) in frame with the TAD derived
from the herpes simplex virus VP16 protein. The construct
Tet–RelA(TAD) has the DNA-binding domain from the bacter-
ial tetracycline repressor fused to the C-terminal portion of
RelA (aa 286–551), which includes its TAD. The transcrip-
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transient co-transfection with the NF-kB-responsive promoter
(kB-luc; Figure 1E), or with a reporter containing seven
tetracycline operons (TetO-luc; Figure 1F). ORF73 impaired
the transcriptional activation of RelA(RHD)–VP16, as assayed
with the kB-luc promoter (Figure 1E). In clear contrast, the
transcriptional activity of Tet–RelA(TAD) was not inhibited
by ORF73 expression, as assessed with the promoter TetO-luc
(Figure 1F). In this case, a higher luciferase activity was
observed, though this was not a speciﬁc effect of ORF73 on
the TAD of RelA, as expression of the viral protein resulted in
an analogous increase of Tet-VP16 transcriptional activity
(data not shown). These results indicate that ORF73 inhibits
the activity of NF-kB proteins by a mechanism that speciﬁ-
cally targets their RHD domain.
RelA nuclear levels are diminished in ORF73-expressing
cells
We proceeded to investigate whether ORF73 would be func-
tioning at the nuclear level by impairing the binding of NF-kB
to DNA kB sites. We performed electromobility shift assays
(EMSA) in the presence of oligonucleotides bearing the
consensus kB site from the immunoglobulin promoter region.
Cells were transiently transfected with ORF73, or control
transfected, and NF-kB activation was induced by TNF. As
illustrated in Figure 2A, NF-kB DNA-binding levels were
Figure 1 ORF73 inhibits NF-kB transcriptional activity by directly targeting NF-kB subunits. (A) ORF73 inhibits TNF-driven NF-kB activity.
HEK 293Tcells were transiently transfected with a NF-kB luciferase reporter vector and with an ORF73-expressing plasmid as indicated. ORF73-
transfected cells (open bars), or control cells (ﬁlled bars), were incubated with the indicated TNF concentrations. NF-kB transcriptional activity
associated with each sample was assayed using a luminometer. Error bars represent standard deviations of the mean from four independent
experiments. A representative immunoblot is shown (bottom) to demonstrate appropriate and equivalent ORF73 expression in all samples.
(B) Reduced levels of IkBa resynthesis in ORF73-expressing cells. HEK 293T cells were transiently transfected to express ORF73, or control
transfected, and after 24h were treated with 50ng/ml of TNF as indicated (top). Total cellular extracts were resolved by SDS–PAGE and
analysed by immunoblotting with anti-IkBa (ﬁrst panel), anti-Myc (second panel) and anti-Actin (third panel) antibodies. Densitometry
analysis of IkBa levels present in each experimental condition, normalised to actin, is shown (bottom). (C) ORF73 is able to inhibit RelA
transcriptional activity as homo- or heterodimers. Cells overexpressing the indicated NF-kB proteins, co-transfected with (open bars) or
without (ﬁlled bars) ORF73-expressing plasmid, were assayed for NF-kB activity as described in (A). (D–F) ORF73 speciﬁcally targets the Rel
homology domain (RHD) of RelA to inhibit its transcriptional activity. HEK 293T cells were transiently co-transfected with (E) a NF-kB
luciferase reporter vector, or (F) a Tet operon responsive construct, together with the indicated chimaeras (depicted in (D)). Filled bars
represent control cells (without ORF73 expression), whereas open bars represent cells transfected with an ORF73-expressing plasmid. The
transcriptional activity associated with each sample was assayed as described above. Error bars represent the standard deviations of the mean
in three independent experiments.  , without; þ, with; a, anti; WB, western blotting.
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reﬂect ORF73 interference with NF-kB DNA binding to kB
sites but rather correlated with diminished levels of nuclear
RelA, as assessed by immunoblotting (Figure 2A, second
panel, compare lanes 2 and 4, and densitometry analysis).
To assess whether ORF73 could itself bind to kB sites, a
supershift assay was performed in the presence of antibodies
directed against RelA (positive control), Actin (unrelated
antibody) or ORF73. The addition of anti-RelA antibody to
the binding reaction caused a supershift in the NF-kB/oligo-
nucleotide complex, which indicates that these complexes
contain RelA protein (Figure 2B, lane 3). In contrast, in the
presence of anti-ORF73 serum no supershift was observed, as
well as when an unrelated antibody was added to the binding
reactions (Figure 2B, lanes 2 and 4), indicating that ORF73
does not bind to kB sites. Taken together, these data raise the
hypothesis that ORF73 may be exerting its inhibitory activity
towards NF-kB by promoting its degradation in the nucleus.
When transiently expressed in resting HEK 293T cells,
ORF73 localised primarily to the nucleus, as assessed by
immunoﬂuorescence (Figure 2C, panel e). TNF treatment
did not affect ORF73 nuclear localisation (Figure 2C, panels
f and h), whereas it caused prompt translocation of RelA from
the cytoplasm to the nucleus (Figure 2C, panels a and b).
However, in cells expressing ORF73, there was a signiﬁcant
decrease in the levels of nuclear RelA after TNF stimulation,
without concomitant accumulation of this protein in the
cytoplasm (Figure 2C, panels d and h). These results are in
Figure 2 RelA nuclear levels are diminished in ORF73-expressing cells. (A) Reduction of NF-kB binding to kB sequences in ORF73-expressing
cells correlates with diminished levels of nuclear RelA. HEK 293T cells were transiently transfected with an ORF73 expression plasmid, or
control transfected. After 24h of culture, cells were stimulated with TNF for 40min, or left unstimulated. Nuclear extracts were prepared and
subjected to electromobility shift assays (EMSAs) using the NF-kB consensus oligonucleotide from the immunoglobulin promoter region. The
percentage of NF-kB binding present in each condition is shown. Nuclear extracts were analysed by immunoblotting to determine the input of
RelA and ORF73 present in each binding reaction. Densitometry analysis of RelA nuclear levels present in each experimental condition,
normalised to the nuclear protein LaminB, is shown. (B) ORF73 protein does not bind to kB sequences. Nuclear extracts from HEK 293Tcells
expressing ORF73 were subjected to a supershift assay using the speciﬁed antibodies. (C) Immunoﬂuorescence analysis of ORF73-expressing
cells. HEK 293Tcells were stimulated with 50ng/ml of TNF for the times indicated and then subjected to immunostaining with anti-RelA and
anti-ORF73 antibodies.  , without; þ, with; a, anti; WB, western blotting.
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NF-kB DNA-binding activity in ORF73-expressing cells
observed in Figure 2A, which likely reﬂect the reduced over-
all levels of nuclear RelA (approximately 70% decrease).
Taken together, these data suggest that ORF73 targets nuclear
RelA in a manner that decreases its level of nuclear expres-
sion after TNF stimulation.
ORF73 triggers poly-ubiquitination and degradation
of nuclear RelA
As RelA nuclear degradation through poly-ubiquitination is
one of the mechanisms through which NF-kB activity can be
downmodulated (Saccani et al, 2004), we investigated
whether ORF73 was targeting nuclear RelA for poly-ubiqui-
tination/degradation. By performing a nickel-nitrilotriacetic
acid (Ni-NTA) pull-down, in the presence of histidine-tagged
ubiquitin, we observed that ORF73 expression signiﬁcantly
enhanced RelA poly-ubiquitination similarly to SOCS1 over-
expression (Figure 3A, compare lanes 5 and 6), an effect
enhanced by the proteasome inhibitor MG132 (Figure 3B,
lane 4), indicating that ORF73-mediated RelA poly-ubiquiti-
nation targets RelA to proteasome degradation. To further
conﬁrm this activity in a more relevant biological context, we
tested the ability of ORF73 to mediate the poly-ubiquitination
of endogenous RelA following stimulation with TNF. Under
the inﬂuence of the proteasomal inhibitor MG132, in com-
parison with control transfected cells, higher levels of poly-
ubiquitinated RelA were detected in the presence of ORF73
(Figure 3C, compare lanes 3 and 6). These data suggest that
ORF73 promotes the ubiquitination of nuclear RelA and its
subsequent proteasomal-dependent degradation.
ORF73 immunoprecipitates exhibit E3 ubiquitin-ligase
activity
As ORF73 does not possess known catalytic domains that
could justify poly-ubiquitination activity, we investigated
whether ORF73 could be part of a cellular E3 ubiquitin-ligase.
To that end, ORF73 was immunoprecipitated from control
transfected, or ORF73-expressing cells, and the respective
immunoprecipitates were subjected to an in vitro ubiquitina-
tion reaction in the presence of exogenous ubiquitin-activat-
ing (E1) and conjugating enzyme (E2) UbcH5a, together with
GST–RelA as a substrate. The presence of ligase activity
directed towards RelA was analysed by immunoblot with an
anti-GST serum. As shown in Figure 3D, in the presence of
ATP, ORF73 immunoprecipitates speciﬁcally catalysed the
poly-ubiquitination of RelA, indicating that ORF73 is a com-
ponent of a cellular E3 ubiquitin-ligase with substrate speci-
ﬁcity towards RelA.
ORF73 interacts with ElonginC and Cullin5
reconstituting an E3 ubiquitin-ligase
Recently, LANA encoded by ORF73 from KSHV was also
shown to possess E3 ubiquitin-ligase activity, acting as a
SOCS protein responsible for substrate recognition and spe-
ciﬁcity (Cai et al, 2006). As E3 ubiquitin-ligases must interact
physically with their targets to exert their function, we
investigated whether ORF73 was associated with RelA
in vivo. In cells overexpressing RelA and co-expressing
ORF73, the latter protein was able to efﬁciently co-immuno-
precipitate RelA (Figure 4A).
We proceeded to test whether ORF73 could associate
with other cellular components known to interact with
SOCS-box-containing proteins, namely ElonginC and
Cullin5. Transiently expressed ORF73 was able to co-immuno-
precipitate with endogenous levels of ElonginC and Cullin5
(Figure 4B). The ability of ORF73 to promote RelA poly-
ubiquitination, combined with its ability to interact with
ElonginC and Cullin5, suggested that the inhibitory effect of
ORF73 on NF-kB activity resided on its ability to assemble an
EC5S E3 ubiquitin-ligase complex.
To conﬁrm that inhibition of NF-kB by ORF73 was depen-
dent on ElonginC and Cullin5, we tested whether ORF73
would inhibit NF-kB activity in cells in which the expression
of those E3 ubiquitin-ligase components was suppressed
using small interfering RNAs (siRNAs). Speciﬁc targeting of
ElonginC and Cullin5 by siRNA was conﬁrmed by a decrease
in the expression levels of these two proteins (Figure 4C).
When endogenous ElonginC and Cullin5 expression was
inhibited, the ability of ORF73 to promote RelA poly-ubiqui-
tination was considerably reduced (Figure 4D), suggesting
that the mechanism used by ORF73 to inhibit NF-kBi s
dependent on the recruitment of cellular proteins to recon-
stitute an E3 ubiquitin-ligase.
Mutation of the SOCS-box-like motif in ORF73
abrogates its inhibitory effect on NF-jB transcriptional
activity
SOCS-box-containing proteins interact with ElonginB/C and
Cullin5/Rbx2 modules through speciﬁc degenerated amino-
acid sequences referred as BC and Cul boxes, respectively
(Kamura et al, 2004). Analysis of MuHV-4 ORF73 primary
structure and by comparison with the previously identiﬁed
BC and Cul5 boxes from LANA of KSHV (Cai et al,2 0 0 6 ) ,
ORF73 appears to lack an obvious BC box. However, close to
the C-terminal end, ORF73 presents a sequence homologous to
LANA Cul5 box: VSCLPLVPGTTQQCVTY (Figure 5A). To
determine whether this region was involved in ORF73 E3
ubiquitin-ligase functions, we substituted SOCS-box consensus
amino acids (underlined) with alanines, and named this ORF73
mutant protein ORF73–SOCS. Immunoﬂuorescence experi-
ments were performed to analyse whether the introduced
mutations affected the subcellular localisation of the protein.
As observed in Figure 5B, ORF73–SOCS localises in the nucleus
of transfected cells. Strikingly, in ORF73–SOCS-expressing cells,
and upon TNF stimulation, RelA nuclear levels are normal and
comparable to those observed in control transfected cells
(Figure 5B, panels d and f). Moreover, in TNF-stimulated
cells, RelA and ORF73–SOCS colocalised in the nucleus
(Figure 5B, panel f), demonstrating that the introduced muta-
tions did not affect ORF73 subcellular localisation, whereas
they affected the ability of ORF73 to promote RelA nuclear
degradation. Immunoprecipitation experiments revealed that
ORF73–SOCS still interacted with RelA (Figure 5C), whereas
lost the ability to recruit ElonginC (Figure 5D) and to a lower
extent Cullin5 (Figure 5E). Taken together, these data revealed
the existence of two distinct functional domains in ORF73: a
domain involved in RelA interaction, which is distinct from the
motif implicated in the recruitment of ElonginC and Cullin5.
Although the latter can be attributed to the ORF73 SOCS-box,
the former remains to be identiﬁed.
Further experiments showed that the ORF73–SOCS mutant
was unable to potentiate RelA poly-ubiquitination
Inhibition of NF-jB and gammaherpesvirus latency
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introduced disrupted the ORF73 SOCS-box domain, and that
the presence of this motif is essential for ORF73 to function as
a mediator of RelA poly-ubiquitination. To investigate
whether ORF73–SOCS failure to promote RelA poly-ubiquiti-
nation would be reﬂected by its inability to suppress NF-kB
transcriptional activity, we performed gene reporter assays in
ORF73–SOCS-expressing cells. The effect of the expression of
ORF73–SOCS on NF-kB transcriptional activity, in conditions
of TNF stimulation, was assessed by quantifying the lucifer-
ase activity present in each experimental condition
(Figure 6B). We observed that disruption of the ORF73–
Figure 3 ORF73 mediates RelA poly-ubiquitination through E3 ubiquitin-ligase activity. (A) ORF73 promotes RelA poly-ubiquitination
similarly to SOCS1 overexpression. HEK 293Tcells were transiently transfected with the indicated plasmids (top). After culture, total cellular
lysates were obtained and ubiquitinated proteins were pulled down using Ni-NTA beads. The levels of poly-ubiquitinated RelA in each
condition were assayed using an anti-RelA antibody. (B) Proteasome inhibition signiﬁcantly enhanced ORF73-mediated RelA poly-ubiquitina-
tion. Cells transfected with the indicated expression plasmids were treated with the proteasome inhibitor MG132 (10mM) for 8h, or left
untreated. RelA poly-ubiquitination present in each condition was assayed as described in (A). (C) ORF73-mediated poly-ubiquitination of
endogenous RelA. HEK 293T cells transiently expressing ORF73 or control cells were stimulated with TNF (50ng/ml) for 3h or left
unstimulated with or without an additional hour of treatment with MG132 (10mM). Total cell lysates were subjected to immunoprecipitation
with an anti-RelA antibody. Immunoprecipitates were analysed by immunoblotting using an anti-ubiquitin (Ubiq) antibody. (D) ORF73
immunoprecipitates exhibit E3 ubiquitin-ligase activity in vitro. HEK 293Tcells were transfected with or without an ORF73-expressing plasmid,
as indicated. After culture, cells were lysed and total cellular extracts were subjected to immunoprecipitation using anti-Myc.
Immunoprecipitates were incubated with recombinant ubiquitin-activating enzyme (E1) and conjugating enzyme (E2) UbcH5a, together
with ubiquitin and GST–RelA as substrates. The reactions were resolved by SDS—PAGE, and the presence of ubiquitinated RelA was analysed
by immunoblotting with an anti-GSTantibody.  , without; þ, with; a, anti; IP, immunoprecipitation; PD, pull down; TCL, total cellular lysates;
WB, western blotting.
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mediated signalling.
Taken together, the data obtained with the ORF73–SOCS
mutant corroborate that ORF73 functions as a SOCS-box-
containing protein to assemble an EC5S
ORF73 E3 ubiquitin-
ligase that recognises RelA and promotes its poly-ubiquitina-
tion. This leads to the subsequent proteasomal-dependent
degradation of RelA, resulting in a strong termination of
RelA/NF-kB activity.
Inhibition of NF-jB signalling is essential for MuHV-4
latency
To directly investigate the biological relevance of inhibition of
NF-kB signalling in gammaherpesvirus pathogenesis, we
generated a recombinant MuHV-4 in which the ORF73 gene
was modiﬁed to recapitulate the amino-acid substitutions of
the ORF73 SOCS-box mutant, designated vSOCS. To assure
that any phenotypic alteration in vSOCS was due to the
engineered mutations in the SOCS-box and not from any
spurious mutation introduced during mutagenesis, a second
independent recombinant virus was engineered (vSOCSi). To
characterise the role of the introduced mutations in a natural
context of infection, we started to compare the kinetics of
viral replication in vitro and during the acute phase of
infection in lungs of Balb/c mice following intranasal inocu-
lation. For comparative purposes, the viruses analysed in-
cluded the vSOCS mutants alongside wild-type MuHV-4
(vWT) and a previously described (Fowler et al, 2003)
Figure 4 ORF73 mediates the assembly of an endogenous EC5S E3 ubiquitin-ligase to promote RelA poly-ubiquitination. (A, B) ORF73 protein
co-immunoprecipitates with RelA, Cullin5 and ElonginC. HEK 293T cells were transiently transfected with the combinations of plasmids
encoding the indicated proteins (top). After culture, cells were lysed and total cellular extracts were subjected to immunoprecipitation using an
anti-ORF73 serum. Immunoprecipitates were analysed by immunoblotting using the indicated antibodies. In addition, representative aliquots
of the total cellular lysates were used to detect the appropriate expression of RelA (A, bottom panel), Cullin5 (B, ﬁfth panel), and ElonginC
(B, bottom panel). (C, D) ElonginC and Cullin5 are required for ORF73-mediated poly-ubiquitination of RelA. (C) HEK 293T cells were
transiently transfected with pools of small interfering (si) RNAs against ElonginC, Cullin5 or non-targeting oligonucleotides. After 48h of
culture, total cellular lysates were obtained and assayed for ElonginC and Cullin5 expression by immunoblotting. (D) ORF73-mediated
ubiquitination of RelA is dependent on endogenous ElonginC and Cullin5 expression. HEK 293T cells were transiently transfected with the
pools of siRNAs indicated above along with the indicated combinations of expression plasmids. Corresponding cellular lysates were obtained
and subjected to Ni-NTA pull down as described in Figure 3A.  , without; þ, with; a, anti; IP, immunoprecipitation; PD, pull down; TCL, total
cellular lysates; WB, western blotting.
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amino acids of the N-terminus of the protein. All these
viruses were analysed for genome integrity (Supplementary
Figure S1) and showed identical in vitro growth
(Supplementary Figure S2), as well as normal replication in
acutely infected lungs (Figure 7A). Next, we proceeded to
investigate the role of the introduced mutations for the ability
of MuHV-4 to induce the expansion of latency in GC B cells.
To this end, we used three independent, but complementary,
experimental assays: ex vivo explant co-culture assays to
measure latent infection in total splenocytes, ﬂow cytometry
coupled to limiting dilution and real-time PCR to quantify the
frequency of viral DNA-positive GC B cells, and in situ
hybridisation analysis to identify virally infected cells within
the spleen, as described earlier (Pires de Miranda et al, 2008).
All three assays used were concurrent in that disruption of
the SOCS-box motif in ORF73 leads to a severe latency deﬁcit,
characterised by its inability to induce the expansion of
latent infection in GC B cells and persistence in the host
(Figure 7B–D). This phenotype was comparable to the pre-
viously reported phenotype (Fowler et al, 2003) of a MuHV-4
lacking a functional ORF73 (v73FS in Figure 7B–D). Thus, at
day 14 post-infection, the levels of the explant co-culture
assay (Figure 7B) and the frequencies of infection in GC B
cells (Figure 7C) obtained for the SOCS-box mutants were
identical to those obtained for v73FS and signiﬁcantly lower
Figure 5 ORF73 interacts with Cullin5 and ElonginC through its SOCS-box-like motif. (A) Schematic representation of LANA and ORF73
proteins with the putative SOCS-box motifs indicated. The two proteins are aligned according to the shared primary sequence homology,
corresponding to amino acids 95–274 and 963–1162 of ORF73 and LANA, respectively (Grundhoff and Ganem, 2003). In the lower panel,
ORF73 primary sequences from different Rhadinoviruses are depicted, showing their consensus SOCS-box motif. Identity and similarity
between amino acids is depicted as dark and light shading, respectively. KSHV, Kaposi’s sarcoma-associated herpesvirus; HVS, herpesvirus
saimiri; RRV, rhesus monkey rhadinovirus. (B) Subcellular localisation of ORF73–SOCS. HEK 293Tcells were stimulated with 50ng/ml of TNF
for the times indicated. After 24h, cells were ﬁxed and subjected to immunostaining with anti-RelA and anti-ORF73 antibodies. (C) The
ORF73–SOCS mutant interacts with RelA. HEK 293Tcells were transfected with the expression plasmids indicated (top). Cellular lysates were
subjected to immunoprecipitation with anti-ORF73 polyclonal serum and the presence of co-immunoprecipitated RelA was assessed by
immunoblotting using anti-RelA antibodies. (D, E) ORF73 SOCS mutant does not co-immunoprecipitate with ElonginC (D) and shows low
afﬁnity towards Cullin5 (E). HEK 293Tcells were transiently transfected with the plasmid combinations indicated (top). The respective total
cellular lysates were subjected to immunoprecipitation using an anti-ElonginC (D) or anti-Cullin5 (E) antibodies. Immunoprecipitates were
resolved by SDS–PAGE and analysed by immunoblotting using the indicated antibodies.  , without; þ, with; a, anti; IP, immunoprecipitation;
TCL, total cellular lysates; WB, western blotting.
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hybridisation analysis of spleen sections from vSOCS- or
v73FS-infected mice exhibited a complete lack of expansion
of latently infected cells (Figure 7D, panels b and c). This was
in clear contrast with vWT where large clusters of latently
infected cells were observed within GCs (Figure 7D, panel a).
Discussion
In this study, we provide compelling evidence that the ORF73
protein from the lymphotropic gammaherpesvirus MuHV-4 is
a strong terminator of NF-kB-dependent transcription.
Several viral proteins have been shown to interfere with the
NF-kB pathway (Hiscott et al, 2006). Here, we report the ﬁrst
example of a viral protein modulating NF-kB signalling/
activity in the nucleus by mimicking a physiological regula-
tory pathway of NF-kB response termination. We show that
the mechanism involves the assembly by ORF73 of an EC5S
E3 ubiquitin-ligase. This complex targets nuclear-activated
RelA for poly-ubiquitination and subsequent proteasomal
degradation. The recruitment of ElonginB/C and Cullin5 is
directed through an unconventional SOCS-box present in
ORF73, whereas RelA recognition is mediated through an
independent, as yet, unidentiﬁed structural motif. Thus,
MuHV-4 has evolved to encode a protein that, in a manner
equivalent to cellular SOCS1 (Ryo et al, 2003), efﬁciently
terminates the NF-kB response. Taking into account that
herpesviruses have co-evolved with their hosts, this ﬁnding
emphasises the physiological relevance of the recently
described regulation of the NF-kB pathway through poly-
ubiquitination and proteasomal degradation of promoter-
bound RelA. This regulatory mechanism has been proposed
to function in synergy with resynthesised IkBa to efﬁciently
terminate NF-kB responses (Saccani et al, 2004). The advan-
tage to the virus is obvious. Independently of the nature of
the stimulus, MuHV-4 directly targets activated NF-kB dimers
bound to kB sites efﬁciently shutting down transcription of
speciﬁc genes. This speciﬁcity is unique to MuHV-4 and
contrasts with other viral mechanisms of NF-kB inhibition
that modulate upstream signalling events, such as the IKK
complex, thus affecting collateral cellular signalling path-
ways. However, this property of a viral protein assembling
an EC5S E3 ubiquitin-ligase is not exclusive to ORF73 of
MuHV-4. The Vif protein encoded by human immuno-
deﬁciency virus-1 (Mehle et al, 2004), the E4ORF6 from
adenovirus (Querido et al, 2001) and the ORF73 homologue
LANA from KSHV (Cai et al, 2006), have recently been shown
to assemble EC5S E3 ubiquitin-ligase complexes through
unconventional SOCS-box motifs. In the case of LANA,
poly-ubiquitination is directed towards the cellular proteins
p53 and VHL. The authors suggested that manipulation of
these tumour suppressors by LANA could potentially create
a propitious environment for the maintenance of latent
infection and progression of KSHV-associated tumours.
Owing to the absence of an amenable animal model of
infection, the direct in vivo role of this LANA function was
not possible to assess.
Unlike KSHV, the biological signiﬁcance of the inhibition of
NF-kB signalling by ORF73 of MuHV-4 for the pathogenesis of
gammaherpesvirus infections can be directly addressed due to
the availability of a murine animal model of infection (Simas
and Efstathiou, 1998). Here, we show that a MuHV-4 recombi-
nant virus with a disrupted SOCS-box motif abrogated the
ability of the virus to expand in GC B cells and persist in the
host. Although we cannot formally exclude that mutating four
amino-acid residues in the SOCS-box motif in ORF73 of MuHV-
4 is compromising its putative role as a viral episome main-
tenance protein, the ﬁndings presented here sustain the inter-
pretation that inhibition of NF-kB activation is critical for
ampliﬁcation of latent virus in GC B cells and for persistence
in the host. Notably, it has been recently shown that blocking
the inhibition of NK-kB signalling mediated by EBV in latently
infected cell lines results in the loss of virus genome copy
number (Lu et al, 2008), providing evidence of a link between
viral genome maintenance and NK-kB inhibition.
Initiation of a GC reaction is reliant not only on speciﬁc
antigen stimulation through the immunoglobulin B-cell
receptor but also on the interaction between the TNFR family
Figure 6 SOCS-box disruption reverts ORF73 inhibition of NF-kB
transcriptional activity. (A) ORF73–SOCS mutant is unable to
promote RelA poly-ubiquitination. HEK 293Tcells were transfected
with the different combinations of plasmids (top). After culture,
poly-ubiquitination of RelAwas assessed as described in Figure 3A.
 , without; þ, with; a, anti; PD, pull down; TCL, total cellular
lysates; WB, western blotting. (B) ORF73–SOCS mutant is unable to
inhibit TNF-driven NF-kB transcriptional activity. HEK 293T cells
were transfected with the NF-kB luciferase reporter together with
the plasmids allowing the expression of the indicated proteins
(bottom). Transfected cells were either stimulated with (open
bars) or without (ﬁlled bars) 50ng/ml of TNF. NF-kB activity
associated with each condition was assayed using a luminometer.
Error bars represent the standard deviations of the mean in three
independent experiments.
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expressed by helper Tcells. This molecular event triggers the
activation of NF-kB transcription factors, the main down-
stream effectors of CD40 signalling. However, in the GC the
gene expression proﬁle of B cells changes markedly. In clear
contrast with what is observed in naı ¨ve B cells, GC B cells fail
to express most CD40 and NF-kB target genes (Basso et al,
2004; Klein and Dalla-Favera, 2008; Shaffer et al, 2001).
Moreover, in GC B cells, the proteins c-Rel and RelA are
localised in the cytoplasm, an indication of NF-kB inactivity
and absence of CD40 signalling (Basso et al, 2004). It is noted
that within the light zone of GCs and in memory B cells
NF-kB members are again localised in the nucleus (Basso
et al, 2004), which is indicative that activation of these
transcriptional factors is needed for exiting from the prolif-
erative GC stage promoting further B-cell differentiation.
Taken together, these data suggest that during B-cell
responses, NF-kB signalling needs to be transiently switched
off during GC proliferation. Putting our present data into this
context, we propose that inhibition of NF-kB by ORF73 is
essential to promote the proliferation of latently infected
B cells within GCs. According to our premise, ORF73 function
relies on prior NF-kB activation and translocation of tran-
scriptionally active dimers to the nucleus, which is critical for
B-cell activation and initiation of GCs. This interpretation
concurs with a previous study showing that constitutive
inhibition of NF-kB from the initial stages of MuHV-4 infec-
tion impairs the establishment of latency (Krug et al, 2007).
Hence, MuHV-4 modulation of NF-kB signalling must be
tightly regulated to support GC formation, which needs
transcriptionally active NF-kB, whereas progression into,
and maintenance of a proliferative GC reaction requires the
Figure 7 ORF73–SOCS virus shows a strong latency deﬁcit. (A) ORF73–SOCS recombinant virus exhibits normal replication in the lung. Wild-
type BALB/c mice were intranasally infected with 10
4 p.f.u. of the indicated viruses. At the indicated days post-infection, lungs were removed
and infectious viruses were titrated by plaque assay. (B) BALB/c mice were intranasally infected with 10
4 p.f.u. of the indicated viruses. At day
14 post-infection, latent viruses in spleens were titrated by infectious centre assay. Each point represents the titre of an individual mouse. The
dashed line represents the limit of detection of the assay. (C) BALB/c mice were intranasally infected with 10
4 p.f.u. of the indicated viruses. At
14 days post-infection, reciprocal frequencies of viral infection in puriﬁed GC B cells (B220
þ/PNA
high) were determined by limiting dilution
and real-time PCR. Data were obtained from pools of ﬁve spleens per group. Bars represent the frequency of viral DNA-positive cells with 95%
conﬁdence intervals. (D) BALB/c mice were intranasally infected with 10
4 p.f.u. of the indicated viruses. At day 14 post-infection, spleens were
removed and processed for in situ hybridisation using probes derived from viral miRNAs 1–6. Panels (a–c) show representative spleen sections
from each group of viruses. All sections are magniﬁed  200.
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ORF73 promotes the proliferation of MuHV-4-infected cells
preventing premature differentiation, another yet unidenti-
ﬁed signal must exist, viral or foreign, supporting further
differentiation of latently infected centroblasts into long-lived
memory B cells. Such timely regulation is consistent with the
pattern of ORF73 transcription that we have shown before to
be restricted to GC B cells but not to newly formed or
follicular B cells (Marques et al, 2003).
Effective colonisation of the host by gammaherpesviruses
requires the proliferation of latently infected B cells
(Stevenson, 2004). Herein, we provide evidence for a novel
ORF73 function, as a mediator of NF-kB activity termination
through the assembly of an Elongin/Cullin/SOCS
ORF73
ubiquitin-ligase that targets the NF-kB subunit RelA. By
mimicking GC physiological inhibition of NF-kB, ORF73
promotes the development of MuHV-4-driven GC-like reac-
tions to expand the host pool of latently infected cells. Given
the intimate association of lymphoproliferative disease with
gammaherpesvirus persistent infection, this study reinforces
NF-kB as a putative target for therapeutic intervention in such
virus-driven malignancies.
Materials and methods
Plasmids
ORF73 expression plasmid was ampliﬁed by PCR from MuHV-4
genome, and the respective PCR product was cloned into pCMV-
Myc (Clontech). pCMV-Myc encoding ORF73–SOCS was generated
by site-directed mutagenesis using QuickChange kit (Stratagene).
Myc-tagged versions of RelA, p50 and c-Rel; RelA chimaeras; and
pC45 (kB-luc) or pBI-5 (TetO-luc) were described earlier (Winkler
et al, 1996; Anrather et al, 1999). Histidine-tagged ubiquitin
plasmid was kindly offered by Dr D Bohmann. Flag-tagged ElonginC
and SOCS1 expression plasmids were provided by Dr E Burstein.
Dr X-F Yu provided the Myc-tagged version of Cullin5.
Immunological reagents
ORF73 antiserum was generated by immunisation of New Zealand
white rabbits (Abcam) with puriﬁed GST–ORF73 protein. Anti-
RelA, anti-IkBa, anti-Cul5, anti-EloC, anti-ubiquitin and anti-
LaminB antibodies were purchased from Santa Cruz Biotechnology.
Antibodies directed to c-Myc and Flag epitopes were from Clontech
and Sigma, respectively. Actin was detected with a rabbit anti-actin
polyclonal antibody (Sigma). Anti-GSTand horseradish peroxidase-
conjugated secondary antibodies were from Amersham Biosciences.
Fluorochrome-labelled secondary antibodies were from Jackson
Immunoresearch.
Tissue culture, DNA/siRNA transfection
HEK 293Tand NIH-3T3-CRE cells were cultured in DMEM plus 10%
FCS, 2mM glutamine, and 100U/ml of penicillin–streptomycin.
BHK-21 cells were cultured in GMEM supplemented as above plus
10% tryptose phosphate broth. Plasmid DNA and siRNAs were
delivered to HEK 293T cells using Fugene 6 (Roche). The
nucleofection system (Amaxa) was used to maximise transfection
efﬁciencies for experiments presented in Figures 1B and 2A,
according to the manufacturer’s instructions. Using this system, a
near pure population of transfectants was obtained. In all
transfections, empty vector was used to normalise the total amount
of plasmidic DNA.
Reporter gene assays
For reported gene assays, HEK 293T cells were transiently
transfected with 300ng of reporter vectors, 900ng of each NF-kB
member and 900ng of ORF73/ORF73–SOCS expression plasmids.
In all transfections, a b-galactosidase expression plasmid (300ng)
was used to normalise luciferase values. After 48h in culture, cells
were left unstimulated or stimulated with appropriate TNF
concentrations for 7h. Cells were washed in PBS and lysed
in 120ml of reporter assay lysis buffer (Promega). Luciferase and
b-galactosidase activities were assayed using Luciferin (Promega)
and Galacton (Tropix), respectively. Light emission in each sample
was quantiﬁed in a luminometer. Results are shown as the fold
induction relative to luciferase activity measured in unstimulated or
control transfected cells.
EMSAs
EMSAs were performed using the Lightshift Chemiluminescent
EMSA kit (Pierce) for the NF-kB consensus oligonucleotide probe
(50-AGTTGAGGGGACTTTCCCAGGC-30, from the immunoglobulin
promoter) 50 end-labelled with biotin (Thermo Scientiﬁc Biopoly-
mers). Binding reactions were made in a total volume of 20mlb y
adding 5mg of nuclear extracts to 20fmol of probe in binding buffer
(20mM HEPES (pH 8.0); 50mM NaCl; 1mM EDTA; 5% glycerol;
0.05mg/ml poly [dI–dC] and 0.5mM DTT). After incubation at room
temperature (r.t.) for 30min, the electromobility of the probe was
analysed in 6% native PAGE. For the supershift assays, antibodies
recognising RelA, ORF73 or Actin were added to nuclear extracts at
a ﬁnal concentration of 0.05mg/ml, and incubated at r.t. for 1h,
prior to the addition of the probe 50 end-labelled with [g
32P]ATP
(Amersham Life Science).
Immunoﬂuorescence analysis
HEK 293T cells grown on poly-L-lysine-coated coverslips were
transiently transfected with 1mg of ORF73-expressing plasmid. After
24h, cells were incubated with medium alone or stimulated with
TNF (50ng/ml) for 15min. Cells were incubated in ﬁxing solution
(5% formaldehyde and 2% sucrose in PBS) for 15min, and
permeabilised (0.1% Triton X-100 in PBS) for 5min. Immunostain-
ing was performed with the appropriate antibodies diluted in PBS.
Following staining, coverslips were washed and mounted onto
microscope slides with Mowiol.
Immunoprecipitations
Transiently transfected HEK 293T cells with expression plasmids
encoding RelA (3mg), Cullin5 (4mg), ElonginC (2mg) and/or ORF73
(3mg) were disrupted in ice-cold lysis buffer containing 10mM
Tris–HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 1mM NaF,
100 mMN a 3VO4 and a cocktail of protease inhibitors (Complete;
Roche). Cleared supernatants were processed for immunoprecipita-
tion essentially as described (Pires de Miranda et al, 2008).
RelA ubiquitination in vivo
For analysis of endogenous RelA ubiquitination, total cellular
lysates, prepared with lysis buffer as above, were immunoprecipi-
tated with anti-RelA antibody and analysed by immunoblotting with
anti-ubiquitin antibody. Levels of in vivo ubiquitinated over-
expressed RelA were determined by pull-down of histidine-tagged
ubiquitin (His6–ubiquitin) with Ni-NTA agarose beads. Cells were
transfected with expression plasmids carrying His6–ubiquitin
(4mg), RelA (3mg) and/or ORF73 (3mg). When appropriate, cells
were incubated in the presence of 10mM of MG132 (Calbiochem).
Transfected cells were lysed with ice-cold urea buffer containing
8M urea, 50mM Tris–HCl (pH 7.5), 300mM NaCl, 1% Triton X-100,
10mM imidazole, 1mM Na3VO4 and Complete. Cleared lysates
were incubated for 3h at 41C with Ni-NTA beads. After incubation,
beads were collected by centrifugation and washed three times with
urea buffer. Proteins were eluted and denatured by boiling in
Laemmli’s buffer and analysed by immunoblotting with anti-RelA
antibodies.
RNA interference
All oligonucleotides were purchased from Ambion. Pre-designed
siRNAs for human ElonginC or Cullin5 were transiently transfected
into HEK 293T cells, at a ﬁnal concentration of 30nM each. Non-
targeting siRNAs were used as controls. At 48h post-transfection,
cells were processed for Ni-NTA pull down.
In vitro ubiquitination assay
Cell lysates from HEK 293T cells transiently expressing ORF73, or
control transfected, were subjected to immunoprecipitation with
anti-Myc. Immunoprecipitates were resuspended in reaction buffer
(40mM HEPES (pH 7.4), 60mM potassium acetate, 1mM EDTA,
2mM DTT, 5mM MgCl2 and 10% glycerol) supplemented with
recombinant ubiquitin (2.5mg) (Biomol International), E1 (50ng),
UbcH5a E2 (100ng) (Calbiochem), GST–RelA (2.5mg) and/or
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incubated for 1h at 301C, resolved by SDS–PAGE and analysed by
immunoblotting with anti-GST antibody.
Generation of recombinant viruses
MuHV-4 vSOCS/vSOCSi recombinant viruses (with the amino-acid
residues at positions 199, 202, 203 and 206 mutated to alanines)
were independently generated by mutagenesis of the viral genome
cloned as a bacterial artiﬁcial chromosome (BAC) (Adler et al,
2000). pCMVmyc-ORF73–SOCS was digested with HindIII and PciI
to isolate the fragment harbouring the desired mutations, which
was inserted into the BamHI-G genomic clone. Recombinant
BamHI-G fragment was subcloned into the BamHI site of pST76K-SR
shuttle plasmid. Shuttle plasmid was transformed into an Escher-
ichia coli strain (DH10B) containing the wild-type MHV-68 BAC
(pHA3). Following a multistep selection procedure, recombinant
BAC clones were identiﬁed by the loss of the internal ORF73 KpnI
restriction site. Both viruses were reconstituted as described (Pires
de Miranda et al, 2008). v73FS recombinant virus was reported
earlier (Fowler et al, 2003).
Analysis of recombinant viruses
BALB/c mice (Instituto Gulbenkian de Cie ˆncia, Portugal) with 6–8
weeks of age were intranasally inoculated with 10
4 p.f.u. in 20mlo f
PBS under halothane anaesthesia. At 3, 7, 10 and 14 days post-
infection, lungs or spleens were removed and processed for
subsequent analysis. Infectious virus titers in freeze-thawed lung
homogenates were determined by suspension assay using BHK-21
cells. Latent viruses were examined using explant co-cultures of
single-cell suspension splenocytes with BHK-21 cells. Plates were
incubated for 4 (suspension assay) or 5 days (co-culture assay), ﬁxed
with 10% formal saline and counterstained with toluidine blue. Viral
plaques were counted with a plate microscope. Frequencies of virus-
genome-positive cells were determined by limiting dilution combined
with real-time PCR, as described earlier (Marques et al, 2003). GC
B-cell (B220
þ,P N A
high) populations were cytometry puriﬁed from
pools of ﬁve spleens using a BD FACSAria Flow Cytometer (BD
Biosciences). The purity of sorted populations was always 497%, as
analysed by ﬂow cytometry. Real-time PCR reactions were performed
as reported (Pires de Miranda et al, 2008). In situ hybridisation was
performed on formalin-ﬁxed, parafﬁn-embedded splenic sections
using digoxigenin-labelled riboprobes, generated by T7 transcription
of pEH1.4 (Simas et al, 1998).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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